Recombinant human monoclonal antibody to Semaphorin 4D/CD100.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Human
Clonality
Monoclonal
Isotype
IgG4SP - Human IgG4 with S228P mutation
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.88 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Pepinemab Biosimilar - Anti-Semaphorin 4D/CD100 Antibody - Low endotoxin, Azide free (A323659) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Pepinemab Biosimilar - Anti-Semaphorin 4D/CD100 Antibody - Low endotoxin, Azide free (A323659) confirms that the purity of this antibody is 100%.
Human C100 HEK293 cells were stained with Pepinemab Biosimilar - Anti-Semaphorin 4D/CD100 Antibody - Low endotoxin, Azide free (A323659) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50 = 0.3227 nM.
Pepinemab Biosimilar - Anti-Semaphorin 4D/CD100 Antibody - Low endotoxin, Azide free (A323659) inhibited the tumor growth of CT26 on BALB/c mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 76.9% at 50 mpk at D24.
Publishing research using Pepinemab Biosimilar - Anti-Semaphorin 4D/CD100 Antibody - Low endotoxin, Azide free (A323659)? Please let us know so that we can list the citation on this page.